-
Mashup Score: 1Q&A: Wearable devices may help IBD patients track flares in ‘the comfort of their homes’ - 2 day(s) ago
Physiological metrics captured via wearable devices may help identify and predict flares in inflammatory bowel disease, Robert P. Hirten, MD, told Healio, and could potentially play a role in remote monitoring of disease activity. “As gastroenterologists, one of the things that we find is that between office visits, there sometimes can be relatively little contact or interaction between
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0Larsucosterol flops on clinical benefit in phase 2b alcohol-associated hepatitis trial - 2 day(s) ago
The AHFIRM trial did not demonstrate a beneficial effect of larsucosterol on 90-day mortality or the need for liver transplant among patients with severe alcohol-associated hepatitis, or AH, according to a study published in NEJM Evidence. “Many marketed drugs and investigational agents have been evaluated for AH over decades, but none have proven consistently effective or received
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
📉After falling short of clinical benefit for #alcohol-associated #hepatitis in phase 2b, can @DURECTCorp's larsucosterol regain momentum in phase 3? Check out the @NEJMEvidence data yourself and join the conversation 💬 https://t.co/llDBvYsyYN
-
-
Mashup Score: 0
Among children with suspected nonperforated appendicitis, antibiotic management appeared inferior to appendectomy, according to results of a large, noninferiority trial published in The Lancet. “The outcomes of this trial offer vital evidence to guide future treatment guidelines for appendicitis,” Agostino Pierro, MD, PhD, senior author and head of general and thoracic surgery at The
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
🤜💊#Appendectomy trumps #antibiotics for children with suspected nonperforated #appendicitis, according to new @TheLancet research out of @SickKidsNews @UofT This may help your discussions on treatment options with patients and their families 💡 👇 https://t.co/R24KM5V9Xl
-
-
Mashup Score: 1US Multi-Society Task Force on CRC revamps colonoscopy bowel prep to set new ‘benchmark’ - 3 day(s) ago
The U.S. Multi-Society Task Force on Colorectal Cancer has released updated guidance establishing a “reasonable benchmark” for the quality of bowel preparation prior to a colonoscopy exam.The task force — comprised of ACG, AGA and ASGE — last updated its recommendations on the level of adequacy for bowel cleansing in 2014. The new guidance was simultaneously published in
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
🚨@AmCollegeGastro, @AmerGastroAssn and @ASGEendoscopy join forces to set a new ‘benchmark’ of quality for #colonoscopy bowel prep #GITwitter, this is the 1⃣st guidance update since 2014... might be good to see what's changed for #endoscopy practice👇 https://t.co/oNhJ256I47
-
-
Mashup Score: 2‘No easy solutions’: Labor shortage requires multipronged approach to recruit, retain GIs - 20 day(s) ago
This month’s Healio Gastroenterology Exclusive highlights a problem that we as physicians “feel” either directly or indirectly nearly every day — labor shortages.This is not only a concern among gastroenterologists but also among advanced practice providers (APPs), certified registered nurse anesthetists (CRNAs) and endoscopy technicians.
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
.@GoHealio #GIs CMO @EdwardLoftus2 said to curb workforce shortage in physicians, hiring or division leads will need to: ✅ Recruit & retain best to GI ✅Be flexible to promote retention ✅ Incentivize oldest to delay retirement Read more 👇 https://t.co/cyQc5eglct
-
-
Mashup Score: 0GIs continue to grapple with growing patient demand, despite shrinking physician shortage - 20 day(s) ago
A 2016 report from the Health Resources and Services Administration National Center for Health Workforce Analysis projected a shortage of 1,630 full-time physicians by 2025 in the field of gastroenterology.However, that is not where the shortage ends. According to Karmen Blackwell, a Health Resources and Services Administration (HRSA) spokesperson, “In 2037, there will be a projected
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
The latest @GoHealio #GI issue is live! Check out expert insights on the continued GI workforce shortage from ⬇️ ▶️ @AmyOxentenkoMD ▶️ @DrSamirAShah1 ▶️ @DanielPambianco Read the full story 👇 https://t.co/id55XSE2Jo https://t.co/4OOP98xhLi
-
-
Mashup Score: 1VIVID-2: Omvoh demonstrates ‘continued durability,’ safety in Crohn’s disease at 2 years - 23 day(s) ago
SAN FRANCISCO — Most patients with moderately to severely active Crohn’s disease who achieved endoscopic response and remission after 52 weeks of Omvoh therapy maintained those results through 104 weeks, according to VIVID-2 study results. “The durability of response and remission among patients who were in endoscopic response at week 52 of the initial study is a critical result
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
At #CCCongess25 @EdBarnesMD said ✅More than 80% of Omvoh responders with Crohn's from VIVID-1 study maintained endoscopic response at 2️⃣ years in VIVID-2. ✅Endoscopic and clinical remission were maintained by 72.5% and 86.9%, respectively. Read ⬇️ https://t.co/frWkIFcgAw
-
-
Mashup Score: 0Most patients with IBD ‘still experience significant challenges’ accessing, affording care - 24 day(s) ago
SAN FRANCISCO — Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due to insurance challenges, and many make financial trade-offs to afford care, survey results showed.“In 2017, the Crohn’s & Colitis Foundation sent a similar health care access survey of IBD patients and found that many patients struggled
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
#CCCongress25 study found IBD patients experience barriers to care, to overcome them: ▶️39.1% reported waiting 2️⃣➕ days to fill prescriptions due to prior authorization issues ▶️28.1% spent 2️⃣➕hours on ☎️ with insurance providers Read 👇 https://t.co/j1Z8FB2Y9y
-
-
Mashup Score: 0Most patients with IBD ‘still experience significant challenges’ accessing, affording care - 24 day(s) ago
SAN FRANCISCO — Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due to insurance challenges, and many make financial trade-offs to afford care, survey results showed.“In 2017, the Crohn’s & Colitis Foundation sent a similar health care access survey of IBD patients and found that many patients struggled
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
#CCCongress25 study found IBD patients experience barriers to care, to overcome them: ▶️39.1% reported waiting 2️⃣➕ days to fill prescriptions due to prior authorization issues ▶️28.1% spent 2️⃣➕hours on ☎️ with insurance providers Read 👇 https://t.co/j1Z8FB2Y9y
-
-
Mashup Score: 0Stelara, Entyvio have ‘comparable’ cardiovascular safety profiles in older adults with IBD - 24 day(s) ago
SAN FRANCISCO — Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel disease, Stelara was associated with reduced all-cause mortality risk over 3 years, data showed. “There are several studies indicating that incidence and prevalence of IBD, along with associated health care codes, is rising more rapidly in
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
More from #CCCongress25 Among older patients with IBD: ▶️No significant differences between Stelara & Entyvio in 3-year risk for a composite of major adverse cardiovascular events ▶️Stelara linked with lower risk for all-cause mortality. Read on👇 https://t.co/g5MohKKryL
-
📳Wearable devices like #AppleWatch, #Fitbit and #Oura Rings “could lay the foundation” for future #IBD care Dr. @RobertHirten @MountSinaiNYC discusses how new wearable tech may open a new chapter of remote disease monitoring 🛜 #GITwitter 👇 https://t.co/cSjbHstVtu